Skip to content

Study · In vitro (cells) · mouse · 1983

4 results

Functional maturation difference between splenocytes that form autologous rosettes in adult thymectomized and aged mice.

Yamanaka R, Good RA, Incefy GS

Thymus1 Jan 1983Cited by 1 (Europe PMC)

PMID6302958 (opens in a new tab)PepBankPUB-06302958

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Activity measurement

    In immature splenocytes from adult thymectomized mice, FTS reduced the ability to form autologous rosettes.

    In plain wordsIn cells from adult thymectomized mice, FTS reduced autologous rosette formation.

    Outcome
    DecreaseAutologous rosette formation
    Study

    mousen: not reported in source

    immature splenocytes from adult thymectomized mice
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Under the influence of facteur thymique sérique (FTS), maturation of isolated populations of immature splenocytes (A-RFC+) from ATx mice and aged animals was accompanied by loss in ability to form autologous rosettes but acquisition of a functional activity was observed only in splenocytes from ATx…
  2. 02LabIn vitro (cells)Activity measurement

    In immature splenocytes from aged mice, FTS reduced the ability to form autologous rosettes.

    In plain wordsIn cells from aged mice, FTS reduced autologous rosette formation.

    Outcome
    DecreaseAutologous rosette formation
    Study

    mousen: not reported in source

    immature splenocytes from aged mice
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Under the influence of facteur thymique sérique (FTS), maturation of isolated populations of immature splenocytes (A-RFC+) from ATx mice and aged animals was accompanied by loss in ability to form autologous rosettes but acquisition of a functional activity was observed only in splenocytes from ATx…
  3. 03LabIn vitro (cells)Activity measurement

    In immature splenocytes from adult thymectomized mice, FTS induced acquisition of functional activity.

    In plain wordsIn cells from adult thymectomized mice, FTS induced functional activity.

    Outcome
    IncreaseAcquisition of functional activity
    Study

    mousen: not reported in source

    immature splenocytes from adult thymectomized mice
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Under the influence of facteur thymique sérique (FTS), maturation of isolated populations of immature splenocytes (A-RFC+) from ATx mice and aged animals was accompanied by loss in ability to form autologous rosettes but acquisition of a functional activity was observed only in splenocytes from ATx…
  4. 04LabIn vitro (cells)Activity measurement

    In immature splenocytes from aged mice, FTS did not induce acquisition of functional activity.

    In plain wordsIn cells from aged mice, FTS did not induce functional activity.

    Outcome
    No significant changeAcquisition of functional activity
    Study

    mousen: not reported in source

    immature splenocytes from aged mice
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Under the influence of facteur thymique sérique (FTS), maturation of isolated populations of immature splenocytes (A-RFC+) from ATx mice and aged animals was accompanied by loss in ability to form autologous rosettes but acquisition of a functional activity was observed only in splenocytes from ATx…

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.